Global Markets
France and others are in talks with the US to avoid trade probes into drug pricing, POLITICO reports
StockNow breaking-news AI analysis
France and partners are negotiating to avoid US trade probes into drug pricing, amid US pressure to link domestic prices to lower European rates, causing regional drug launch delays.
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.